Identification of Fasnall as a therapeutically effective Complex I inhibitor
Dzmitry Mukha, Jena Dessain, Seamus O’Connor, Katherine A. Pniewski, Fabrizio Bertolazzi, Jeet H. Patel, Mary C. Mullins, Zachary T. Schug
This study identifies Fasnall as a Complex I inhibitor that mimics FASN inhibition, showing anti-tumor effects without neurological side effects.
bioRxiv · May 3, 2024 · PreprintCancer Biology